advertisement

Topcon

Abstract #19925 Published in IGR 9-4

Intravenous administration of clonidine reduces intraocular pressure and alters ocular blood flow

Weigert G; Resch H; Luksch A; Reitsamer HA; Fuchsjager-Mayrl G; Schmetterer L; Garhofer G
British Journal of Ophthalmology 2007; 91: 1354-1358


AIM: To evaluate the effect of intravenously administered clonidine on ocular blood flow in healthy volunteers. METHODS: A randomised, double-masked, placebo-controlled, two-way crossover study was performed in 12 healthy young volunteers. Clonidine (0.2 μg/kg/min) or placebo was administered intravenously over ten minutes. The effects of clonidine were studied at baseline and up to 150 minutes after infusion. Ocular haemodynamics were measured using laser Doppler flowmetry, laser Doppler velocimetry and a retinal vessel analyser. RESULTS: Clonidine significantly decreased mean arterial pressure (MAP) and intraocular pressure (IOP). Calculated ocular perfusion pressure decreased significantly by -8.7 ± 8.7% after infusion of clonidine (p < 0.01 vs placebo). Retinal arterial diameters increased by +4.4 ± 2.7% (p = 0.012 vs placebo), whereas no significant change was observed in retinal veins. Red blood cell velocity decreased by -16 ± 14% (p < 0.01 vs placebo) after infusion of clonidine. Hence, calculated retinal blood flow decreased by -14 ± 12% (p = 0.033 vs placebo). Choroidal blood flow increased by +18 ± 19% (p < 0.01 vs placebo) and optic nerve head blood flow increased by +16 ± 23% (p = 0.046 vs placebo) 30 minutes after administration of clonidine but both returned to baseline thereafter. CONCLUSION: The short-time increase in choroidal and optic nerve head blood flow indicates a transient vasodilatory effect of clonidine due to an unknown mechanism. The decrease in retinal blood flow indicates clonidine-induced vasoconstriction in the retinal microvasculature.

Dr. G. Wiegert, Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria


Classification:

11.3.3 Apraclonidine, brimonidine (Part of: 11 Medical treatment > 11.3 Adrenergic drugs)
6.11 Bloodflow measurements (Part of: 6 Clinical examination methods)



Issue 9-4

Change Issue


advertisement

Oculus